Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.75 EUR | -1.60% | -0.15% | -16.09% |
02-02 | Boiron: nearly 600,000 shares tendered to the OPAS | CF |
01-11 | Boiron: OPAS open from January 11 to 31 | CF |
Business Summary
Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin.
There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties).
BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries.
Net sales are distributed geographically as follows: France (52.4%), Europe (22.5%), North America (22.6%) and other (2.5%).
Number of employees: 2,813
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Homeopathic Specialties
52.4
%
| 258 | 56.7 % | 280 | 52.4 % | +8.38% |
Common Name Homeopathic Medicines
34.6
%
| 195 | 42.8 % | 185 | 34.6 % | -5.28% |
Other Health Products
13.1
%
| 2 | 0.5 % | 70 | 13.1 % | +3,171.80% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
France
52.4
%
| 254 | 55.8 % | 280 | 52.4 % | +10.21% |
North America
22.6
%
| 84 | 18.4 % | 121 | 22.6 % | +43.71% |
Europe
22.5
%
| 109 | 23.8 % | 120 | 22.5 % | +10.87% |
Other Countries
2.5
%
| 9 | 1.9 % | 13 | 2.5 % | +53.99% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 30/06/11 | |
Thierry Boiron
CHM | Chairman | 63 | 17/09/96 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hervé Coulpier
CTO | Chief Tech/Sci/R&D Officer | - | 30/04/17 |
Patrice Varraut
COO | Chief Operating Officer | - | 31/12/08 |
Fabrice Rey
IRC | Investor Relations Contact | - | - |
Juliette Baudry
HRO | Human Resources Officer | - | - |
Frédéric Ducher
LAW | General Counsel | - | 31/05/15 |
Eric Lambert
SEC | Corporate Secretary | - | 31/05/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 80 | 21/05/03 | |
Thierry Boiron
CHM | Chairman | 63 | 17/09/96 |
Philippe Brun
BRD | Director/Board Member | 64 | 26/05/21 |
Jacky Abécassis
BRD | Director/Board Member | 79 | 05/05/87 |
Michéle Boiron
BRD | Director/Board Member | 79 | 17/09/96 |
Anne Borfiga
BRD | Director/Board Member | 52 | 26/05/21 |
Director/Board Member | 49 | 22/05/13 | |
Corporate Officer/Principal | 61 | 31/12/15 | |
Grégory Walter
BRD | Director/Board Member | 46 | 17/05/17 |
Sylvain Mossaz
BRD | Director/Board Member | 48 | 16/12/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,545,408 | 2,265,995 ( 12.92 %) | 183,225 ( 1.044 %) | 12.92 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Boiron Laboratories Pvt Ltd.
|
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.09% | 626M | |
+35.04% | 5.92B | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
-7.89% | 1.68B | |
+0.09% | 1.65B | |
-12.97% | 1.53B |
- Stock Market
- Equities
- BOI Stock
- Company BOIRON